Kusama, Yoshiki, Fukui, Sadahiro, Maruyama, Makiko et al. · Pediatrics international : official journal of the Japan Pediatric Society · 2022 · DOI
This study examines whether ME/CFS can develop in children after they have COVID-19. The researchers reviewed existing information about how post-COVID conditions might lead to ME/CFS symptoms in young patients. This is important because understanding the link between COVID-19 and ME/CFS could help doctors recognize and support children who develop this condition after a viral infection.
Understanding whether COVID-19 can trigger ME/CFS in children is clinically significant for diagnosis and management. Early recognition of post-COVID ME/CFS in pediatric patients may improve outcomes through appropriate medical support and activity management.
This review does not provide new primary data establishing causation between COVID-19 and ME/CFS development. It cannot determine the prevalence or incidence of ME/CFS following COVID-19 in children, nor does it establish whether post-COVID syndrome and ME/CFS are distinct entities or manifestations of the same underlying mechanism.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →